Accordingly, genetic deletion of ERO1α inhibited pancreatic tumor proliferation, colony formation, and cellular ROS production in vitro, while cell transfer into a mouse xenograft model confirmed a profound reduction in tumor development in vivo. The gene discussed is ERO1A; the disease is pancreatic neoplasm.